JNJ-632
featured

    WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 555279

CAS#: 1572510-42-9

Description: JNJ-632 is a potent HVV capsid assembly modulator and HBV replication inhibitor with EC50 of 100-200 nM for genotypes A-D. Administration of JNJ-632 in HBV genotype D infected chimeric mice, resulted in a 2.77 log reduction of the HBV DNA viral load.


Chemical Structure

img
JNJ-632
CAS# 1572510-42-9

Theoretical Analysis

MedKoo Cat#: 555279
Name: JNJ-632
CAS#: 1572510-42-9
Chemical Formula: C18H19FN2O4S
Exact Mass: 378.11
Molecular Weight: 378.418
Elemental Analysis: C, 57.13; H, 5.06; F, 5.02; N, 7.40; O, 16.91; S, 8.47

Price and Availability

Size Price Availability Quantity
50mg USD 450
100mg USD 750
200mg USD 1250
500mg USD 1950
1g USD 2950
2g USD 5450
5g USD 7650
Bulk inquiry

Synonym: JNJ-632; JNJ 632; JNJ632.

IUPAC/Chemical Name: (S)-N-(4-fluoro-3-methylphenyl)-3-(N-(tetrahydrofuran-3-yl)sulfamoyl)benzamide

InChi Key: JIZGLOVJKCSHTH-HNNXBMFYSA-N

InChi Code: InChI=1S/C18H19FN2O4S/c1-12-9-14(5-6-17(12)19)20-18(22)13-3-2-4-16(10-13)26(23,24)21-15-7-8-25-11-15/h2-6,9-10,15,21H,7-8,11H2,1H3,(H,20,22)/t15-/m0/s1

SMILES Code: O=C(NC1=CC=C(F)C(C)=C1)C2=CC=CC(S(=O)(N[C@@H]3COCC3)=O)=C2

Appearance: Solid powder

Purity: >98% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility: Soluble in DMSO

Shelf Life: >3 years if stored properly

Drug Formulation: This drug may be formulated in DMSO

Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code: 2934.99.9001

More Info:

Product Data:
Biological target: JNJ-632 is a hepatitis B virus (HBV) capsid assembly modulator (CAM).
In vitro activity: CAM (capsid assembly modulator) JNJ-632 is a novel and potent inhibitor of HBV replication in vitro across genotypes A to D. It induces the formation of morphologically intact viral capsids, as demonstrated by size exclusion chromatography and electron microscopy studies. Reference: Antimicrob Agents Chemother. 2017 Jul 25;61(8):e00560-17. https://pubmed.ncbi.nlm.nih.gov/28584155/
In vivo activity: Administration of JNJ-632 in HBV genotype D infected chimeric mice resulted in a 2.77 log reduction of the HBV DNA viral load. Reference: J Med Chem. 2018 Jul 26;61(14):6247-6260. https://pubmed.ncbi.nlm.nih.gov/29906396/

Solubility Data

Solvent Max Conc. mg/mL Max Conc. mM
Solubility
Ethanol 76.0 200.84

Preparing Stock Solutions

The following data is based on the product molecular weight 378.42 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
Formulation protocol: 1. Berke JM, Dehertogh P, Vergauwen K, Van Damme E, Mostmans W, Vandyck K, Pauwels F. Capsid Assembly Modulators Have a Dual Mechanism of Action in Primary Human Hepatocytes Infected with Hepatitis B Virus. Antimicrob Agents Chemother. 2017 Jul 25;61(8):e00560-17. doi: 10.1128/AAC.00560-17. PMID: 28584155; PMCID: PMC5527576. 2. Vandyck K, Rombouts G, Stoops B, Tahri A, Vos A, Verschueren W, Wu Y, Yang J, Hou F, Huang B, Vergauwen K, Dehertogh P, Berke JM, Raboisson P. Synthesis and Evaluation of N-Phenyl-3-sulfamoyl-benzamide Derivatives as Capsid Assembly Modulators Inhibiting Hepatitis B Virus (HBV). J Med Chem. 2018 Jul 26;61(14):6247-6260. doi: 10.1021/acs.jmedchem.8b00654. Epub 2018 Jul 3. PMID: 29906396.
In vitro protocol: 1. Berke JM, Dehertogh P, Vergauwen K, Van Damme E, Mostmans W, Vandyck K, Pauwels F. Capsid Assembly Modulators Have a Dual Mechanism of Action in Primary Human Hepatocytes Infected with Hepatitis B Virus. Antimicrob Agents Chemother. 2017 Jul 25;61(8):e00560-17. doi: 10.1128/AAC.00560-17. PMID: 28584155; PMCID: PMC5527576.
In vivo protocol: 1. Vandyck K, Rombouts G, Stoops B, Tahri A, Vos A, Verschueren W, Wu Y, Yang J, Hou F, Huang B, Vergauwen K, Dehertogh P, Berke JM, Raboisson P. Synthesis and Evaluation of N-Phenyl-3-sulfamoyl-benzamide Derivatives as Capsid Assembly Modulators Inhibiting Hepatitis B Virus (HBV). J Med Chem. 2018 Jul 26;61(14):6247-6260. doi: 10.1021/acs.jmedchem.8b00654. Epub 2018 Jul 3. PMID: 29906396.

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.
=
x
x
g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Dilution Calculator

Calculate the dilution required to prepare a stock solution.
x
=
x

1: Vandyck K, Rombouts G, Stoops B, Tahri A, Vos A, Verschueren W, Wu Y, Yang J,
Hou F, Huang B, Vergauwen K, Dehertogh P, Berke JM, Raboisson PJMB. Synthesis and
Evaluation of N-phenyl-3-sulfamoyl-benzamide Derivatives as Capsid Assembly
Modulators inhibiting Hepatitis B Virus (HBV). J Med Chem. 2018 Jun 15. doi:
10.1021/acs.jmedchem.8b00654. [Epub ahead of print] PubMed PMID: 29906396.


2: Berke JM, Dehertogh P, Vergauwen K, Van Damme E, Mostmans W, Vandyck K,
Pauwels F. Capsid Assembly Modulators Have a Dual Mechanism of Action in Primary
Human Hepatocytes Infected with Hepatitis B Virus. Antimicrob Agents Chemother.
2017 Jul 25;61(8). pii: e00560-17. doi: 10.1128/AAC.00560-17. Print 2017 Aug.
PubMed PMID: 28584155; PubMed Central PMCID: PMC5527576.